RecruitingNCT05502133
Identification of Acute Intermittent Porphyria Modifying Genes
Studying Acute intermittent porphyria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Principal Investigator
- Robert J Desnick, Ph.D, MDIcahn School of Medicine at Mount Sinai
- Enrollment
- 150 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05502133 on ClinicalTrials.gov